Skip to Content
Merck
CN

157481

4-Nitrochalcone

99%

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
O2NC6H4CH=CHCOC6H5
CAS Number:
Molecular Weight:
253.25
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
214-949-5
MDL number:
Assay:
99%
Form:
solid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


assay

99%

form

solid

mp

158-160 °C (lit.)

functional group

ketone, nitro, phenyl

SMILES string

[O-][N+](=O)c1ccc(\C=C\C(=O)c2ccccc2)cc1

InChI

1S/C15H11NO3/c17-15(13-4-2-1-3-5-13)11-8-12-6-9-14(10-7-12)16(18)19/h1-11H/b11-8+

InChI key

WDZGGAFMGIOIQS-DHZHZOJOSA-N

General description

Mutagenic activity of 4-nitrochalcone on two strains of Salmonella typhimurium (TA98 and TA100) with and without rat liver microsomal and cytosolic enzymes has been tested.

Application

4-Nitrochalcone was used in the synthesis of 2,3-dibromo-4-nitrochalcone.


Storage Class

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Synthesis and Photochromic Properties of New Heterocyclic Derivatives of 1, 3-Diazabicyclo [3.1. 0] Hex-3-Ene.
Mahmoodi NO, et al.
J. Chin. Chem. Soc., 54(3), 635-641 (2007)
K A Rashid et al.
Mutation research, 169(3), 71-79 (1986-03-01)
31 p-monosubstituted chalcones (E-1, 3-diphenylpropene-1-one) and the corresponding oxides (E-1-benzoyl-2-phenyloxirane) were tested for mutagenic activity on two strains of Salmonella typhimurium (TA98 and TA100) with and without rat liver microsomal and cytosolic enzymes. Highest mutagenicity (3.0 revertants/nmole in either strain)
João Paulo Assolini et al.
European journal of pharmacology, 884, 173392-173392 (2020-08-01)
The Leishmaniasis treatment currently available involves some difficulties, such as high toxicity, variable efficacy, high cost, therefore, it is crucial to search for new therapeutic alternatives. Over the past few years, research on new drugs has focused on the use



Global Trade Item Number

SKUGTIN
157481-25G04061838743381